|Articles|June 26, 2017

2015 Ontario Measles Outbreak Underscores the Need For Immunizations

Author(s)Einav Keet

A new report on a measles outbreak that occurred in Ontario in 2015 emphasizes the importance of immunization in a globalized world.

Researchers have released a new report on an unusual outbreak of measles that occurred in the Canadian province of Ontario in 2015, highlighting the importance of epidemiological investigation and surveillance in the effort to eradicate the virus.

While the World Health Organization (WHO) notes that there were 134,200 measles deaths worldwide in 2015, Canada has largely eradicated the virus through widespread vaccination. According to the Centers for Disease Control and Prevention (CDC), the measles, mumps, and rubella (MMR) vaccine protects against the 3 highly contagious viruses; a 2-dose schedule is 97% effective at preventing measles, while a single dose schedule is 93% effective. Measles — marked by high fever, cough, oral Koplik spots, and a telltale rash – is no longer common in countries such as Canada and the United States where immunization rates have helped populations obtain herd immunity. However, outbreaks of the virus can still occur in these countries, particularly in under-vaccinated communities, and as global travel connects individuals with parts of the world where measles is still common.

In a recent report in the CDC journal Emerging Infectious Diseases, a team of researchers in Canada have examined an outbreak of measles that occurred in the province of Ontario in early 2015. The outbreak period occurred that year from January 25, when the first case was reported to Toronto Public Health, to February 17, and involved a total of 18 cases reported by 4 public health units. Investigators confirmed the immunization status of 14 out of the 18 patients; of these patients, 3 adults and 6 children were not immunized, while 2 adults were fully immunized. None of the infected individuals reported recent travel, and the investigators were unable to identify a “source patient,” though molecular epidemiologic analysis suggested that all cases likely came from “a single importation of measles virus genotype D4.”

The report notes that the outbreak was “unusual” in that cases involved “a unique strain of virus and no known association among primary case-patients.” Furthermore, investigation yielded no answer regarding the common source of the virus, though the high rate of measles vaccination in Ontario likely helped prevent a larger outbreak. The cases did occur in mostly unimmunized or under-immunized individuals, in a part of the province with a multicultural population and many international travelers.

“This outbreak is an excellent example of why it is important that everybody ensures that their immunization status is up to date,” senior author Shelley L. Deeks, MD, interim chief of Communicable Disease, Emergency Preparedness and Response for Public Health Ontario, told Contagion®. “We live in a global and interconnected world. We are continually exposed to other people in our everyday lives. For a disease such as measles, that is extremely contagious and transmitted through the air, an individual can be exposed to an infected person and be at risk of disease with limited interaction.”

Dr. Deeks notes that measles can be transmitted through limited contact with a contagious individual, a noninfected individual can catch it by sitting beside someone on a plane who is infected, or walking into a room an hour after an infected individual has left; it’s also easily spread to others through coughing and sneezing.

Canada experienced a total of 196 cases of measles in 2015. Two-dose vaccination coverage of 95% or higher is recommended to achieve measles herd immunity, the authors noted in the report. “Herd immunity is important as there are some individuals who are not able to receive the vaccine,” said Dr. Deeks, such as individuals who are immunocompromised or who are too young to receive vaccination. “If most of the population is vaccinated, then the disease will not continue to spread because we no longer have a pool of susceptible people. As measles is very infectious, we need a high proportion of the population to be vaccinated to stop the ongoing spread of this disease.”


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.